{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:10:45Z","timestamp":1778544645504,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004530","name":"Universiti Putra Malaysia","doi-asserted-by":"publisher","award":["GP-IPM\/2020\/9684800"],"award-info":[{"award-number":["GP-IPM\/2020\/9684800"]}],"id":[{"id":"10.13039\/501100004530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118729","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:44:31Z","timestamp":1765007071000},"page":"118729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhancing colorectal cancer treatment with a triple therapy approach involving 5-fluorouracil, thymoquinone, Polygonum minus"],"prefix":"10.1016","volume":"193","author":[{"given":"Kshidan Marim Abdullah","family":"Salem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Malami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim Wei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Zuki Abu","family":"Bakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noorjahan Banu Mohammed","family":"Alitheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Alsubbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidu","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2580-8300","authenticated-orcid":false,"given":"Ahmad Faizal Abdull","family":"Razis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norsharina","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118729_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22485-5","article-title":"Polygonumins A, a newly isolated compound from the stem of Polygonum minus Huds, with potential medicinal activities","volume":"8","author":"Ahmad","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118729_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s43046-025-00261-7","article-title":"Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation","volume":"37","author":"Aslam","year":"2025","journal-title":"J. Egypt. Natl. Canc. Inst."},{"issue":"23","key":"10.1016\/j.biopha.2025.118729_bib3","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2025.118729_bib4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/ph17050598","article-title":"Exploring synergistic interactions between natural compounds and conventional chemotherapeutic drugs in preclinical models of lung cancer","volume":"17","author":"Bo\u021ba","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118729_bib5","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118729_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10555-023-10126-x","article-title":"Resveratrol as sensitizer in colorectal cancer plasticity","volume":"43","author":"Brockmueller","year":"2024","journal-title":"Cancer Metastas.. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118729_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ddc4010004","article-title":"Synergy, additive effects, and antagonism of drugs with plant bioactive compounds","volume":"4","author":"Chaachouay","year":"2025","journal-title":"Drugs Drug Candidates"},{"issue":"2","key":"10.1016\/j.biopha.2025.118729_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"The mass-action law based algorithm for drug combination studies and CI index","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118729_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0974-8490.147125","article-title":"Review on polygonum minus. Huds, a commonly used food additive in Southeast Asia","volume":"7","author":"Christapher","year":"2015","journal-title":"Pharmacogn. Res."},{"key":"10.1016\/j.biopha.2025.118729_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16081011","article-title":"Exploring the therapeutic potential of 5-fluorouracil-loaded calcium carbonate nanoparticles combined with natural compound thymoquinone for colon cancer treatment","volume":"16","author":"Deng","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118729_bib11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/antiox13091030","article-title":"5-Fluorouracil in combination with calcium carbonate nanoparticles loaded with antioxidant thymoquinone against colon cancer: synergistically therapeutic potential and underlying molecular mechanism","volume":"13","author":"Deng","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.118729_bib12","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3892\/mmr.2014.2008","article-title":"Colon cancer cells treated with 5-fluorouracil exhibit changes in polylactosamine-type N-glycans","volume":"9","author":"Gao","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2025.118729_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-024-00239-2","article-title":"Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer","volume":"6","author":"Gu","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.biopha.2025.118729_bib14","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.2147\/IJN.S190830","article-title":"Modified methods of nanoparticles synthesis in ph-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line","volume":"14","author":"Hamidu","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.biopha.2025.118729_bib15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118729_bib16","article-title":"Protosappanin B enhances the chemosensitivity of 5-fluorouracil in colon adenocarcinoma by regulating the LINC00612\/microRNA-590-3p\/Golgi phosphoprotein 3 axis","volume":"15","author":"Hong","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.biopha.2025.118729_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115902","article-title":"The relationship between tumor metabolism and 5-fluorouracil resistance","volume":"218","author":"Hu","year":"2023","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118729_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109142","article-title":"Natural products for treating colorectal cancer: a mechanistic review","volume":"117","author":"Huang","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118729_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49604-1","article-title":"Corilagin enhances the anti-tumor activity of 5-FU by downregulating the expression of GRP 78","volume":"13","author":"Li","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118729_bib20","doi-asserted-by":"crossref","first-page":"63937","DOI":"10.18632\/oncotarget.11570","article-title":"Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118729_bib21","first-page":"62","article-title":"17\u03b2-estradiol enhances 5-fluorouracil anti-cancer activities in colon cancer cell lines","volume":"10","author":"Mahbub","year":"2022","journal-title":"Med. Sci."},{"key":"10.1016\/j.biopha.2025.118729_bib22","article-title":"Cancer resistance to therapies against the EGFR\u2013RAS\u2013RAF pathway: the role of MEK","volume":"110","author":"Martinelli","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2025.118729_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176979","article-title":"Resistance to 5-fluorouracil: the molecular mechanisms of development in colon cancer cells","volume":"983","author":"Radenkovi\u0107","year":"2024","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118729_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111285","article-title":"5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118729_bib25","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2023.3719","article-title":"Quercetin reverses 5-fluorouracil resistance in colon cancer cells by modulating the NRF2\/HO-1 pathway","volume":"67","author":"Tang","year":"2023","journal-title":"Eur. J. Histochem"},{"key":"10.1016\/j.biopha.2025.118729_bib26","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1016\/j.yexcr.2010.09.003","article-title":"Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620","volume":"316","author":"Tentes","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2025.118729_bib27","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.18632\/oncotarget.7567","article-title":"Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer","volume":"7","author":"Toden","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118729_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.12980\/APJTB.4.2014C1255","article-title":"A recent review on phytochemical constituents and medicinal properties of kesum (Polygonum minus Huds.)","volume":"4","author":"Vikram","year":"2014","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.biopha.2025.118729_bib29","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1007\/s13277-014-1807-2","article-title":"The mechanisms of 5-FU-PLA-O-CMC-NPS-mediated inhibition of the proliferation of colorectal cancer cell line SW480","volume":"35","author":"Wu","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.biopha.2025.118729_bib30","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.7150\/jca.20196","article-title":"Curcumin enhances the anticancer effect of 5-fluorouracil against gastric cancer through down-regulation of COX-2 and NF-\u03baB signaling pathways","volume":"8","author":"Yang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2025.118729_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2025.105853","article-title":"Exploring the anti-colon cancer potential of Polygonum minus: integrating in vitro and in silico studies","volume":"64","author":"Yang","year":"2025","journal-title":"Food Biosci."},{"key":"10.1016\/j.biopha.2025.118729_bib32","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/cam4.1114","article-title":"In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells","volume":"6","author":"Zhao","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2025.118729_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153547","article-title":"Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer","volume":"85","author":"Zheng","year":"2021","journal-title":"Phytomedicine"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:23:17Z","timestamp":1778541797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S0753332225009230"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118729","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing colorectal cancer treatment with a triple therapy approach involving 5-fluorouracil, thymoquinone, Polygonum minus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118729"}}